| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0166-6851(99)00197-8 |
| P698 | PubMed publication ID | 10743606 |
| P50 | author | Hans Westerhoff | Q15989741 |
| Barbara Marleen Bakker | Q21551979 | ||
| Fred Opperdoes | Q55221768 | ||
| P2093 | author name string | P A Michels | |
| P2860 | cites work | Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase | Q27617894 |
| Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors | Q27618611 | ||
| Crystal Structure of Glycosomal Glyceraldehyde-3-phosphate Dehydrogenase from Leishmania mexicana: Implications for Structure-Based Drug Design and a New Position for the Inorganic Phosphate Binding Site | Q27729721 | ||
| A Linear Steady-State Treatment of Enzymatic Chains. General Properties, Control and Effector Strength | Q28246120 | ||
| Sugar transporters from bacteria, parasites and mammals: structure-activity relationships | Q28292451 | ||
| An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei | Q28306793 | ||
| Structure-based drug design: progress, results and challenges | Q30419784 | ||
| Recent advances in identifying and validating drug targets in trypanosomes and leishmanias. | Q33542293 | ||
| Compartmentation of carbohydrate metabolism in trypanosomes | Q34685609 | ||
| Contribution of glucose transport to the control of the glycolytic flux in Trypanosoma brucei | Q35615506 | ||
| Metabolic control analysis: a survey of its theoretical and experimental development | Q35860764 | ||
| Compartmentation of phosphoglycerate kinase in Trypanosoma brucei plays a critical role in parasite energy metabolism | Q36314647 | ||
| Structure, function, and biogenesis of glycosomes in kinetoplastida | Q39044849 | ||
| Compartmentation of glycolysis in trypanosomes: a potential target for new trypanocidal drugs | Q39249876 | ||
| The inhibition of pyruvate transport across the plasma membrane of the bloodstream form of Trypanosoma brucei and its metabolic implications. | Q39591858 | ||
| Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis | Q40437048 | ||
| The control of flux. | Q40481103 | ||
| Inhibition of the glycolytic enzymes in the trypanosome: an approach in the development of new leads in the therapy of parasitic diseases | Q40667215 | ||
| Regulation and control of compartmentalized glycolysis in bloodstream form Trypanosoma brucei | Q41040967 | ||
| Purification, morphometric analysis, and characterization of the glycosomes (microbodies) of the protozoan hemoflagellate Trypanosoma brucei | Q41457278 | ||
| Trypanosoma brucei: Trypanocidal effect of salicylhydroxamic acid plus glycerol in infected rats | Q41680538 | ||
| Differential regulation of two distinct families of glucose transporter genes in Trypanosoma brucei | Q43181987 | ||
| New approach to screening drugs for activity against African trypanosomes | Q44983593 | ||
| Inhibition of glyceraldehyde-3-phosphate dehydrogenase by pentalenolactone in Trypanosoma brucei | Q46211203 | ||
| Glycolysis in bloodstream form Trypanosoma brucei can be understood in terms of the kinetics of the glycolytic enzymes. | Q52274817 | ||
| Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design. | Q53741874 | ||
| What Controls Glycolysis in Bloodstream FormTrypanosoma brucei? | Q57393902 | ||
| Subcellular Compartmentation of Glycolytic Intermediates in Trypanosoma brucei | Q58843045 | ||
| Specificity of glucose transport in Trypanosoma brucei. Effective inhibition by phloretin and cytochalasin B | Q68036120 | ||
| Prospects for antiparasitic drugs. The case of Trypanosoma brucei, the causative agent of African sleeping sickness | Q74263636 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-10 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Molecular and Biochemical Parasitology | Q15752756 |
| P1476 | title | Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs | |
| P478 | volume | 106 |
| Q35917161 | A plethora of targets, a paucity of drugs: progress towards the development of novel chemotherapies for human African trypanosomiasis |
| Q41836315 | A probabilistic approach to identify putative drug targets in biochemical networks |
| Q27639996 | Anomalous differences of light elements in determining precise binding modes of ligands to glycerol-3-phosphate dehydrogenase |
| Q36131358 | Aquaporins from pathogenic protozoan parasites: structure, function and potential for chemotherapy |
| Q27643297 | Characterization, kinetics, and crystal structures of fructose-1,6-bisphosphate aldolase from the human parasite, Giardia lamblia |
| Q32062530 | Cloning of a pyruvate phosphate dikinase from Trypanosoma cruzi |
| Q45007511 | Cloning, heterologous expression, and characterization of three aquaglyceroporins from Trypanosoma brucei |
| Q46041637 | Comparative molecular docking of antitrypanosomal natural products into multiple Trypanosoma brucei drug targets |
| Q89662547 | Computational approaches for drug discovery against trypanosomatid-caused diseases |
| Q73062299 | Current awareness on comparative and functional genomics |
| Q34071727 | Drug uptake via nutrient transporters in Trypanosoma brucei. |
| Q41972663 | Enzymatic inhibitory activity and trypanocidal effects of extracts and compounds from Siphoneugena densiflora O. Berg and Vitex polygama Cham |
| Q38867546 | Experimental and in silico analyses of glycolytic flux control in bloodstream form Trypanosoma brucei |
| Q34059533 | Expression of genes encoding F(1)-ATPase results in uncoupling of glycolysis from biomass production in Lactococcus lactis |
| Q37094845 | Functional genomics of Plasmodium falciparum using metabolic modelling and analysis |
| Q92774155 | Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity |
| Q43085754 | Glucose transporters in parasitic protozoa |
| Q41730167 | Immunological response and protection of mice immunized with plasmid encoding Toxoplasma gondii glycolytic enzyme malate dehydrogenase |
| Q47293352 | In Vitro Testing of Potential Entamoeba histolytica Pyruvate Phosphate Dikinase Inhibitors |
| Q44103737 | Leishmania donovani phosphofructokinase. Gene characterization, biochemical properties and structure-modeling studies |
| Q27641298 | Leishmania mexicana glycerol-3-phosphate dehydrogenase showed conformational changes upon binding a bi-substrate adduct |
| Q37768672 | Mathematical modeling: bridging the gap between concept and realization in synthetic biology |
| Q35550669 | Metabolic Engineering: Advances in Modeling and Intervention in Health and Disease |
| Q34550535 | Metabolic control analysis in drug discovery and disease |
| Q37217309 | Metabolic control analysis: a tool for designing strategies to manipulate metabolic pathways. |
| Q36850342 | Molecular identification and characterization of an essential pyruvate transporter from Trypanosoma brucei |
| Q37452948 | Network dynamics |
| Q90644432 | New concepts in feedback regulation of glucose metabolism |
| Q35080823 | Nutrient transport and pathogenesis in selected parasitic protozoa |
| Q34837180 | Promising therapeutic targets for antileishmanial drugs |
| Q58842888 | Recent advances in trypanosomatid research: genome organization, expression, metabolism, taxonomy and evolution |
| Q44103725 | Schemes of flux control in a model of Saccharomyces cerevisiae glycolysis |
| Q27656083 | Structure of Insoluble Rat Sperm Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) via Heterotetramer Formation with Escherichia coli GAPDH Reveals Target for Contraceptive Design |
| Q27639073 | Structure of Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase complexed with chalepin, a natural product inhibitor, at 1.95 A resolution |
| Q26748657 | Synthetic biology and regulatory networks: where metabolic systems biology meets control engineering |
| Q35063614 | Systematic construction of kinetic models from genome-scale metabolic networks |
| Q34585708 | Targeting of toxic compounds to the trypanosome's interior |
| Q41971759 | The Peculiar Glycolytic Pathway in Hyperthermophylic Archaea: Understanding Its Whims by Experimentation In Silico. |
| Q46844882 | The development of an immobilized enzyme reactor containing glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi: the effect of species' specific differences on the immobilization. |
| Q43210237 | Trypanocidal activity of the ethyl esters of N-propyl and N-isopropyl oxamates on intracellular amastigotes of Trypanosoma cruzi acute infected mice |
| Q35537890 | Why is the Plasmodium falciparum hexose transporter a promising new drug target? |
Search more.